Startseite/Aktien/CNSP

CNSP

USD

CNS Pharmaceuticals Inc. Common Stock

$6.600-0.420 (-5.983%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$7.020

Hoch

$7.020

Tief

$6.500

Volumen

0.01M

Unternehmensfundamentaldaten

Marktkapitalisierung

3.8M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.05M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $4.93Aktuell $6.600Hoch $114

Ähnliche Nachrichten

12. Sept. 2025 · 14:08

Analyst Upgrades

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

Maxim Group analyst Jason McCarthy upgrades CNS Pharma from Hold to Buy and announces $20 price target.

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

3. Sept. 2025 · 13:15

AccessWire

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

27. Aug. 2025 · 12:00

GlobeNewswire

IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of